William P. Forbes, EVP Research&Devel & CDO at SALIX PHARMACEUTICALS LTD (SLXP), sold 4,297 shares at $50.00 ($215K) on 2012-02-13, disclosed to the SEC on 2012-02-15.
Scheduled sale ($215k) by EVP Research&Devel & CDO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XAIR | BUY | 2023-04-03 | $33K | — | Filing → |
| XAIR | BUY | 2023-03-20 | $32K | — | Filing → |
| XAIR | BUY | 2019-11-15 | $25K | — | Filing → |